Eric Rowinsky
Eric Rowinsky is the Executive Chairman of the Board of Directors at Rgenix and Chair of its Clinical Advisory Board.
Eric is principally focused on the comprehensive development and registration strategies of cancer therapeutics of all types. Eric obtained his B.A. degree from New York University and his M.D. from the Vanderbilt University
Country:
United States